Definium Therapeutics Us, Inc.
Clinical trials sponsored by Definium Therapeutics Us, Inc., explained in plain language.
-
Microdosing LSD for ADHD? new trial shows promise
Symptom relief CompletedThis study tested whether repeated low doses of LSD (called MM120) can safely help adults with ADHD. Fifty-three adults took either the drug or a placebo, and researchers measured changes in their ADHD symptoms using a standard rating scale. The goal was to see if this approach c…
Phase: PHASE2 • Sponsor: Definium Therapeutics US, Inc. • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC
-
LSD-Based drug shows promise for anxiety in Mid-Stage trial
Symptom relief CompletedThis study tested four different doses of MM120 (a form of LSD) against a placebo in 198 adults with generalized anxiety disorder. The goal was to see which dose best reduces anxiety symptoms, measured by a standard anxiety scale. Participants took the drug once and were followed…
Phase: PHASE2 • Sponsor: Definium Therapeutics US, Inc. • Aim: Symptom relief
Last updated May 15, 2026 11:54 UTC